| Prevalence of anti-SARS-CoV-2 antibodies among blood donors in Northern Cape, KwaZulu-Natal, Eastern Cape, and Free State provinces of South Africa in January 2021. W Sykes, L Mhlanga, R Swanevelder, TN Glatt, E Grebe, C Coleman, ... Research Square, 2021 | 79 | 2021 |
| Estimates of prevalence of anti-SARS-CoV-2 antibodies among blood donors in South Africa in March 2022 J Bingham, R Cable, C Coleman, TN Glatt, E Grebe, L Mhlanga, C Nyano, ... Research square, 2022 | 25 | 2022 |
| Convalescent plasma in the treatment of moderate to severe COVID-19 pneumonia: a randomized controlled trial (PROTECT-Patient Trial) K van den Berg, TN Glatt, M Vermeulen, F Little, R Swanevelder, C Barrett, ... Scientific reports 12 (1), 2552, 2022 | 22 | 2022 |
| Estimates of prevalence of anti-SARS-CoV-2 antibodies among blood donors in eight provinces of South Africa in November 2021 R Cable, C Coleman, T Glatt, E Grebe, L Mhlanga, C Nyoni, N Pieterson, ... Research Square, 2022 | 12 | 2022 |
| Prevalence of anti-SARS-CoV-2 antibodies among blood donors in South Africa during the period January-May 2021 M Vermeulen, L Mhlanga, W Sykes, C Coleman, N Pietersen, R Cable, ... | 12 | 2021 |
| COVID-19: Convalescent plasma as a potential therapy K Van Den Berg, M Vermeulen, TN Glatt, S Wasserman, CL Barrett, ... South African Medical Journal 110 (7), 562-563, 2020 | 12 | 2020 |
| International forum on the collection and use of COVID‐19 convalescent plasma: protocols, challenges and lessons learned: summary AZ Al‐Riyami, T Burnouf, M Yazer, D Triulzi, LT Kumaş, L Sağdur, ... Vox Sanguinis 116 (10), 1117-1135, 2021 | 11 | 2021 |
| International forum on the collection and use of COVID‐19 convalescent plasma: responses AZ Al‐Riyami, T Burnouf, M Yazer, D Triulzi, LT Kumaş, L Sağdur, ... Vox Sanguinis 116 (10), e71-e120, 2021 | 8 | 2021 |
| Donor deferral and return patterns–a South African perspective TN Glatt, R Swanevelder, S Prithvi Raj, J Mitchel, K van den Berg ISBT Science Series 16 (2), 178-187, 2021 | 6 | 2021 |
| Rapid and Successful Implementation of a COVID-19 Convalescent Plasma Programme—The South African Experience TN Glatt, C Hilton, C Nyoni, A Swarts, R Swanevelder, J Cowley, ... Viruses 13 (10), 2050, 2021 | 4 | 2021 |
| The world apheresis association registry, 2023 update H Vrielink, K Le Poole, B Stegmayr, J Kielstein, G Berlin, O Ilhan, ... Transfusion and apheresis science, 103831, 2023 | 3 | 2023 |
| Rapid and Successful Implementation of a COVID-19 Convalescent Plasma Programme—The South African Experience Viruses 2021, 13, 2050 TN Glatt, C Hilton, C Nyoni, A Swarts, R Swanevelder, J Cowley, ... Coronaviruses Research in BRICS Countries, 47, 2021 | 2 | 2021 |
| The multifactorial pathogenesis of severe central anemia in a cohort of HIV‐positive patients. N Glatt, E Schapkaitz, J Vaughan International Journal of Laboratory Hematology 41 (4), 2019 | 2 | 2019 |
| The evolution and interpretation of seroprevalence of SARS‐CoV‐2 antibodies among South African blood donors from the Beta to Omicron variant‐driven waves M Vermeulen, L Mhlanga, W Sykes, R Cable, C Coleman, N Pietersen, ... Vox Sanguinis 119 (3), 242-251, 2024 | | 2024 |
| VIABILITY OF HAEMATOPOIETIC STEM CELLS-FROM LABORATORY TO BEDSIDE T Glatt, K Ramadwa, R Cockeran BONE MARROW TRANSPLANTATION 58 (SUPP 1), 370-370, 2023 | | 2023 |
| A 12-MONTH RETROSPECTIVE DESCRIPTIVE STUDY OF OCCURRENCES FOR THE SOUTH AFRICAN NATIONAL BLOOD SERVICES APHERESIS COLLECTION AND THE STEM CELL PROCESSING FACILITIES LE Anderson, TN Glatt, R Cockeran BONE MARROW TRANSPLANTATION 58 (SUPP 1), 695-695, 2023 | | 2023 |
| THE USE OF PRE-CD34 RESULTS AS A PREDICTOR OF ENDCD34 RESULTS Y Skosana, T Glatt, T Gcayiya, R Cockeran BONE MARROW TRANSPLANTATION 58 (SUPP 1), 610-610, 2023 | | 2023 |
| AN APHERESIS COLLECTION AND PROCESSING FACILITY SYSTEM IN THE SOUTH AFRICAN SETTING L Anderson, V Iaconianni, TN Glatt BONE MARROW TRANSPLANTATION 58 (SUPP 1), 690-690, 2023 | | 2023 |
| CRYOPRESERVATION OF ALLOGENEIC HAEMATOPOIETIC STEM CELLS-THE SOUTH AFRICAN COVID-19 EXPERIENCE TN Glatt, H Mahosi, R Cockeran BONE MARROW TRANSPLANTATION 58 (SUPP 1), 612-612, 2023 | | 2023 |
| P‐PH‐8| The Evolution and Interpretation of Seroprevalence of SARS‐CoV‐2 Antibodies Among Blood Donors from the Beta to Omicron Variant Driven Waves M Vermeulen, W Sykes, K van den Berg, R Cable, C Coleman, T Glatt, ... Transfusion 63, 236A-237A, 2023 | | 2023 |
